STOCK TITAN

Basel Medical Group (Nasdaq: BMGL) reports chief partnership role exit

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Basel Medical Group Ltd reported that its Group Chief Partnership Officer, Mr. Vincent Teo, has submitted his resignation. The company is in the process of determining the terms of his separation. Basel Medical Group expressed its appreciation for Mr. Teo’s service during his tenure with the company.

Positive

  • None.

Negative

  • None.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2025

 

Commission File Number: 001-42527

 

Basel Medical Group Ltd

 

6 Napier Road,

Unit #02-10/11 Gleneagles Medical Centre

Singapore 258499

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

Resignation of Chief Partnership Officer

 

Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) has received a letter of resignation from its Group Chief Partnership Officer, Mr. Vincent Teo. The Company is presently determining the terms of separation with Mr. Teo. The Company would like to thank Mr. Teo for his service to the Company during his tenure.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Basel Medical Group Ltd
   

 

  By: /s/ Darren Yen Feng Chhoa
  Name: Dr. Darren Yen Feng Chhoa
  Title: Chief Executive Officer
     
Date: August 13, 2025    

 

 

 

FAQ

What did Basel Medical Group Ltd (BMGL) disclose in this Form 6-K?

Basel Medical Group Ltd disclosed that its Group Chief Partnership Officer, Mr. Vincent Teo, has resigned and that the company is determining the terms of his separation.

Which executive is leaving Basel Medical Group Ltd (BMGL)?

The Group Chief Partnership Officer, Mr. Vincent Teo, has submitted his resignation to Basel Medical Group Ltd.

Are the separation terms for BMGL’s Group Chief Partnership Officer finalized?

No, Basel Medical Group Ltd stated that it is presently determining the terms of separation with Mr. Vincent Teo.

How did Basel Medical Group respond to Vincent Teo’s resignation?

Basel Medical Group Ltd thanked Mr. Vincent Teo for his service to the company during his tenure.

Who signed the BMGL Form 6-K about the officer resignation?

The report was signed on behalf of Basel Medical Group Ltd by Dr. Darren Yen Feng Chhoa, the company’s Chief Executive Officer.

Does this BMGL filing mention any financial results or transactions?

No, this report focuses on the resignation of the Group Chief Partnership Officer and does not discuss financial results or major transactions.

Basel Medical Group Ltd

NASDAQ:BMGL

BMGL Rankings

BMGL Latest News

BMGL Latest SEC Filings

BMGL Stock Data

11.65M
8.58M
Medical Care Facilities
Healthcare
Link
Singapore
Singapore